Literature DB >> 8616877

Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells.

K Terasawa1, H Furumoto, M Kamada, T Aono.   

Abstract

The expression of simple mucin-type carbohydrate antigens, Tn and sialyl-Tn antigens, was evaluated by immunohistochemical staining with monoclonal antibodies in normal squamous epithelium, dysplasia, carcinoma in situ, and invasive squamous cell carcinoma of the uterine cervix. The expression of the Tn antigen detected by HB-Tn1 and B1.1 was found in 17 (20%) and 19 (23%) of the 83 invasive carcinomas, respectively, but was not found in the 36 normal squamous epithelia, 22 severe dysplasias, or 24 carcinomas in situ. The sialyl-Tn antigen was detected by HB-STn1 and TKH-2 in 14 (64%) and 11 (50%) of the 22 severe dysplasias, 13 (54%) and 10 (42%) of the 24 carcinomas in situ and 48 (58%) and 42 (51%) of the 83 invasive carcinomas, respectively, but was completely absent in 36 normal squamous epithelia. Coexpression of the sialyl-Tn antigen was observed in 89% of the cases expressing the Tn antigen. No significant difference was observed between the immunoreactivities of the antigens in the metastatic lymph nodes and primary tumors. No correlation was found between the expression of each antigen and clinical state, histologic type, depth of invasion, parametrial spread, lymphatic and vessel permeation, lymph node metastasis, or 5-year survival rate. The expression of Tn and sialyl-Tn demonstrates a specific change in the neoplastic progression from carcinoma in situ to invasive carcinoma and from normal to dysplasia, respectively, in squamous cell neoplastic lesions of the cervix. Tn and sialyl-Tn antigens may be useful markers for biologic investigation of neoplastic transformation in cervical squamous cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8616877

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  28 in total

1.  A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines.

Authors:  Andrea Medeiros; Nora Berois; Marcelo Incerti; Sylvie Bay; Laura Franco Fraguas; Eduardo Osinaga
Journal:  J Nat Med       Date:  2012-05-30       Impact factor: 2.343

Review 2.  Molecular screening of cancer: the future is here.

Authors:  Sudhir Srivastava
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 3.  Perspectives on the significance of altered glycosylation of glycoproteins in cancer.

Authors:  Y J Kim; A Varki
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

4.  Promoters of Human Cosmc and T-synthase Genes Are Similar in Structure, Yet Different in Epigenetic Regulation.

Authors:  Junwei Zeng; Rongjuan Mi; Yingchun Wang; Yujing Li; Li Lin; Bing Yao; Lina Song; Irma van Die; Arlene B Chapman; Richard D Cummings; Peng Jin; Tongzhong Ju
Journal:  J Biol Chem       Date:  2015-06-10       Impact factor: 5.157

5.  Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.

Authors:  Annamaria de Laurentiis; Marco Gaspari; Camillo Palmieri; Cristina Falcone; Enrico Iaccino; Giuseppe Fiume; Ornella Massa; Mariorosario Masullo; Franca Maria Tuccillo; Laura Roveda; Ubaldo Prati; Olga Fierro; Immacolata Cozzolino; Giancarlo Troncone; Pierfrancesco Tassone; Giuseppe Scala; Ileana Quinto
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

6.  Identification, cloning, and characterization of two N-acetylgalactosamine-binding lectins from the albumen gland of Helix pomatia.

Authors:  Anatoliy Markiv; Diluka Peiris; G Paul Curley; Mark Odell; Miriam V Dwek
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

7.  Glycosylations versus conformational preferences of cancer associated mucin core.

Authors:  J Schuman; D Qiu; R R Koganty; B M Longenecker; A P Campbell
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

8.  Sialyl Lewis x expression in cervical scrapes of premalignant lesions.

Authors:  Noé Velázquez-Márquez; Gerardo Santos-López; Lucio Jiménez-Aranda; Julio Reyes-Leyva; Verónica Vallejo-Ruiz
Journal:  J Biosci       Date:  2012-12       Impact factor: 1.826

9.  GalNAcalpha1-3Gal, a new prognostic marker for cervical cancer.

Authors:  Qian Li; Miriam R Anver; Zhitao Li; Donna O Butcher; Jeffrey C Gildersleeve
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

10.  A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell-lymphatic endothelium interaction.

Authors:  Carla Danussi; Anna Coslovi; Cristiana Campa; Maria T Mucignat; Paola Spessotto; Fulvio Uggeri; Sergio Paoletti; Alfonso Colombatti
Journal:  Glycobiology       Date:  2009-06-15       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.